Weightlifting athlete receives sanction

18 May 2018

The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of the Australian Weightlifting Federation to impose a four year ban on athlete Brendan Southwick for the presence and use of two prohibited substances.

ASADA collected a urine sample from Mr Southwick at the Northern Territory Weightlifting Competition in Palmerston on 9 April 2017.

His sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, which detected the presence of Clenbuterol and Furosemide.

Clenbuterol is a non-specified substance banned both in and out of competition under the S1 class of Anabolic Agents on the World Anti-Doping Agency’s Prohibited List. It is not approved for human use in Australia and the side effects include headaches, hypotension, anxiety, tremors, insomnia, nausea and heart palpitations.

Furosemide is banned both in and out of completion under the S5 class of Diuretics and Masking Agents on the World Anti-Doping Agency’s Prohibited List. Side effects can include muscle cramps, drowsiness and blurred vision. 

Mr Southwick was deemed to have waived his right to a hearing and accepted the sanction, which was backdated to commence on 20 June 17 to account for time already served under a mandatory provisional suspension. 

As a result, he is ineligible to participate, as an athlete or support person, in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 20 June 2021.

ASADA is committed to protecting the right of clean athletes to fair competition. If you are aware of any suspicious doping activity, you can report it anonymously via the ASADA website: www.asada.gov.au/report-doping or call us on 13 000 27232.